V. Leclair, M. Hudson, and S. M. Proudman, Subsets in systemic sclerosis: one size does not fit all, JSRD, vol.1, issue.3, pp.298-306, 2016.
DOI : 10.5301/jsrd.5000212

A. Tyndall, U. Mueller-ladner, and M. Matucci-cerinic, Systemic sclerosis in Europe: first report from the EULAR Scleroderma Trials And Research (EUSTAR) group database. Annals of the Rheumatic Diseases, pp.1107-1107, 2005.
DOI : 10.1136/ard.2005.036038

URL : http://ard.bmj.com/content/64/7/1107.full.pdf

U. A. Walker, A. Tyndall, and L. Czirják, Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database, Annals of the Rheumatic Diseases, vol.66, issue.6, pp.754-763, 2007.

F. Meier, K. W. Frommer, and R. Dinser, Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database, Annals of the Rheumatic Diseases, vol.71, issue.8, pp.1355-1360, 2012.

N. Goh, S. R. Desai, S. Veeraraghavan, D. M. Hansell, S. J. Copley et al., Interstitial lung disease in systemic sclerosis: a simple staging system, Am J Respir Crit Care Med, vol.177, pp.1248-1254, 2008.
DOI : 10.1164/rccm.200706-877oc